4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-000480
Chief Financial Officer gave up 4,578 shares (to pay taxes)
- Chief Financial Officer acquired 11,188 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tsuchimoto Kim R · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-31 | Exercise or conversion : show line 1 in the form | +9,957 | 47,943 | D | ||
| 2023-12-31 | Shares withheld for taxes : show line 2 in the form | −4,073 | $0.34 | $1,386 | 43,870 | D |
| 2024-01-01 | Exercise or conversion : show line 3 in the form | +1,231 | 45,101 | D | ||
| 2024-01-01 | Shares withheld for taxes : show line 4 in the form | −505 | $0.34 | $172 | 44,596 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-31 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −9,957 | 95,556 | D |
| 2024-01-01 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −1,231 | 94,325 | D |
Loading xslF345X05/rdgdoc.xml…